Open Access
Vet. Res.
Volume 41, Number 3, May–June 2010
Number of page(s) 13
Published online 13 January 2010
How to cite this article Vet. Res. (2010) 41:30
  • Bachrach H.L., Foot-and-mouth disease virus, Annu. Rev. Microbiol. (1968) 22:201–244. [CrossRef] [PubMed] [Google Scholar]
  • Barnett P.V., Carabin H., A review of emergency foot-and-mouth disease (FMD) vaccines, Vaccine (2002) 20:1505–1514. [CrossRef] [PubMed] [Google Scholar]
  • Bitko V., Musiyenko A., Shulyayeva O., Barik S., Inhibition of respiratory viruses by nasally administered siRNA, Nat. Med. (2005) 11:50–55. [CrossRef] [PubMed] [Google Scholar]
  • Brown C.C., Piccone M.E., Mason P.W., McKenna T.S.-C., Grubman M.J., Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle, J. Virol. (1996) 70:5638–5641. [PubMed] [Google Scholar]
  • Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., , RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice, J. Virol. (2004) 78:6900–6907. [CrossRef] [PubMed] [Google Scholar]
  • Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., , Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo, J. Virol. (2006) 80:3559–3566. [CrossRef] [PubMed] [Google Scholar]
  • Chenard G., Miedema K., Moonen P., Schrijver R.S., Dekker A., A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology, J. Virol. Methods (2003) 107:89–98. [CrossRef] [PubMed] [Google Scholar]
  • Curtiss R.T., Hassan J.O., Herr J., Kelly S.M., Levine M., Mahairas G.G., , Nonrecombinant and recombinant avirulent salmonella vaccine, in: Talwar G.P., Rao K.V.S., Chauhan V.S. (Eds.), Recombinant and synthetic vaccines, Norosa Publishing House, New Delhi, India, 1994, pp. 340–351. [Google Scholar]
  • Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., , Oral somatic transgene vaccination using attenuated S. typhimurium, Cell (1997) 91:765–775. [CrossRef] [PubMed] [Google Scholar]
  • Darji A., Lage S.Z., Garbe A.I., Chakraborty T., Weiss S., Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier, FEMS Immunol. Med. Microbiol. (2000) 27:341–349. [CrossRef] [PubMed] [Google Scholar]
  • De los Santos T., Wu Q., de Avila Botton S., Grubman M.J., Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus, Virology (2005) 335:222–231. [CrossRef] [PubMed] [Google Scholar]
  • Dietrich G., Gentschev I., Hess J., Ulmer J.B., Kaufmann S.H.E., Goebel W., Delivery of DNA vaccines by attenuated intracellular bacteria, Trends Immunol. Today (1999) 20:251–253. [CrossRef] [Google Scholar]
  • Fang X.W., Li Y.L., Huang C.B., Zheng M., Feng W.D., Sun W., Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of Salmonella choleraesuis, Acta Veterinaria Zootechnica Sinica (1981) 12:99–106. [Google Scholar]
  • Fountaine T.M., Wood M.J.A., Wade-Martins R., Delivering RNA interference to the mammalian brain, Curr. Gene Ther. (2005) 5:399–410. [CrossRef] [PubMed] [Google Scholar]
  • Geisbert T.W., Hensley L.E., Kagan E., Yu E.Z., Geisbert J.B., Daddario-DiCaprio K., , Post exposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference, J. Infect. Dis. (2006) 193:1650–1657. [CrossRef] [PubMed] [Google Scholar]
  • Gitlin L., Karelsky S., Andino R., Short interfering RNA confers intracellular antiviral immunity in human cells, Nature (2002) 418:430–434. [CrossRef] [PubMed] [Google Scholar]
  • Gitlin L., Andino R., Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing, J. Virol. (2003) 77:7159–7165. [CrossRef] [PubMed] [Google Scholar]
  • Gray J., Fedorka-Cray P., Stabel T., Ackermann M., Influence of inoculation route on the carrier state of Salmonella choleraesuis in swine, Vet. Microbiol. (1995) 47:43–59. [CrossRef] [PubMed] [Google Scholar]
  • Grubman M.J., Baxt B., Foot-and-mouth disease, Clin. Microbiol. Rev. (2004) 17:465–493. [CrossRef] [PubMed] [Google Scholar]
  • Grubman M.J., de los Santos T., Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?, Trends Immunol. (2005) 26:65–68. [CrossRef] [PubMed] [Google Scholar]
  • Hohjoh H., RNA interference (RNA (i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells, FEBS Lett. (2002) 521:195–199. [CrossRef] [PubMed] [Google Scholar]
  • Hohjoh H., Enhancement of RNAi activity by improved siRNA duplexes, FEBS Lett. (2004) 557:193–198. [CrossRef] [PubMed] [Google Scholar]
  • Holen T., Amarzguioui M., Wiiger M.T., Babaie E., Prydz H., Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor, Nucleic Acids Res. (2002) 30:1757–1766. [CrossRef] [PubMed] [Google Scholar]
  • Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y., Inhibition of foot-and-mouth disease virus replication by small interfering RNA, J. Gen. Virol. (2004) 85:3213–3217. [CrossRef] [PubMed] [Google Scholar]
  • Kim S., Lee K., Park J., Ko Y., Joo Y., Kim H., Park J., Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo, Antiviral. Res. (2008) 80:178–184. [CrossRef] [PubMed] [Google Scholar]
  • King A.M., Underwood B.O., McCahon D., Newman J.W., Brown F., Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK, Nature (1981) 293:479–480. [CrossRef] [PubMed] [Google Scholar]
  • Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., , Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque, Nat. Med. (2005) 11:944–951. [PubMed] [Google Scholar]
  • Liu M., Chen W., Ni Z., Yan W., Fei L., Jiao Y., , Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome, Virology (2005) 336:51–59. [CrossRef] [PubMed] [Google Scholar]
  • Liu M., Niu X., Yan J., Yan W., Zheng Z., Immure response induced by oral DNA vaccination against FMDV delivered by attenuated Salmonella choleraesuis C500, Front. Biol. China (2006) 2:110–114. [CrossRef] [Google Scholar]
  • Lu S., Cullen B.R., Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis, J. Virol. (2004) 78:12868–12876. [CrossRef] [PubMed] [Google Scholar]
  • Mason P.W., Piccone M.E., Mckenna T.S., Chinsangaram J., Grubman M.J., Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate, Virology (1997) 227:96–102. [CrossRef] [PubMed] [Google Scholar]
  • Mercado R., Vijh S., Allen S.E., Kerksiek K., Pilip I.M., Pamer E.G., Early programming of T cell populations responding to bacterial infection, J. Immunol. (2000) 165:6833–6839. [PubMed] [Google Scholar]
  • Mohapatra J.K., Sanyal A., Hemadri D., Tosh C., Kumar R.M., Bandyopadhyay S.K., Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome, Biochem. Biophys. Res. Commun. (2005) 329:1133–1138. [CrossRef] [PubMed] [Google Scholar]
  • O’Reilly E.K., Kao C.C., Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure, Virology (1998) 252:287–303. [CrossRef] [PubMed] [Google Scholar]
  • Paglia P., Medina E., Arioli I., Guzman C.A., Colombo M.P., Gene transfer in dendritic cells induced by oral DNA vaccination with Salmonella typhimurium results in protective immunity against a murine fibrosarcoma, Blood (1998) 92:3172–3176. [PubMed] [Google Scholar]
  • Pereira H.G., Foot-and-mouth disease, in: Gibbs E.P.J. (Ed.), Virus diseases of food animals, Academic Press, Inc., San Diego, California, 1981, pp. 333–363. [Google Scholar]
  • Prato Murphy M.L., Meyer R.F., Mebus C., Schudel A.A., Rodriguez M., Analysis of sites of FMDV persistence in carrier cattle via the polymerase chain reaction, Arch. Virol. (1994) 136:299–307. [CrossRef] [PubMed] [Google Scholar]
  • Reed L.J., Muench H.A., A simple method of estimating fifty percent end points, Am. J. Hyg. (1938) 27:493–497. [Google Scholar]
  • Rigden R.C., Carrasco C.P., Barnett P.V., Summerfield A., McCullough K.C., Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs, Vaccine (2003) 21:1466–1477. [CrossRef] [PubMed] [Google Scholar]
  • Shen C., Buck A.K., Liu X., Winkler M., Reske S.N., Gene silencing by adenovirus-delivered siRNA, FEBS Lett. (2003) 539:111–114. [CrossRef] [PubMed] [Google Scholar]
  • Shiau A.L., Chen Y.L., Liao C.Y., Huang Y.S., Wu C.L., Prothymosin enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis, Vaccine (2001) 19:3947–3956. [CrossRef] [PubMed] [Google Scholar]
  • Song E., Lee S.K., Dykxhoorn D.M., Novina C., Zhang D., Crawford K., , Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages, J. Virol. (2003) 77:7174–7181. [CrossRef] [PubMed] [Google Scholar]
  • Srinivasan A., Foley J., Ravindran R., McSorley S.J., Low-dose Salmonella infection evades activation of flagellin-specific CD4 T cells, J. Immunol. (2004) 173:4091–4099. [PubMed] [Google Scholar]
  • Steitz T.A., A mechanism for all polymerases, Nature (1998) 391:231–232. [CrossRef] [PubMed] [Google Scholar]
  • Sun T., Lu P., Wang X., Localization of infection-related epitopes on the nonstructural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes, J. Virol. Methods (2004) 119:79–86. [CrossRef] [PubMed] [Google Scholar]
  • Ter Brake O., Konstantinova P., Ceylan M., Berkhout B., Silencing of HIV-1 with RNA interference: a multiple shRNA approach, Mol. Ther. (2006) 14:883–892. [CrossRef] [PubMed] [Google Scholar]
  • Woo P., Wong L., Zheng B., Yuen K., Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium, Vaccine (2001) 19:2945–2954. [CrossRef] [PubMed] [Google Scholar]
  • Zhao L.J., Jian H., Zhu H., Specific gene inhibition by adenovirus-mediated expression of small interfering RNA, Gene (2003) 316:137–141. [CrossRef] [PubMed] [Google Scholar]
  • Zimmermann T.S., Lee A.C.H., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., , RNAi-mediated gene silencing in non-human primates, Nature (2006) 441:111–114. [CrossRef] [PubMed] [Google Scholar]